Sun, Dec 21, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Amida Capital Management hires Renata Cirne as Chief Marketing Officer

Friday, July 08, 2011
Opalesque Industry Update - Amida Capital Management II, LLC, a New York based investment manager, has hired Renata Cirne to assume the position of Chief Marketing Officer. Ms. Cirne will report to David Rich, Amida’s Founder and Chief Investment Officer.

“Renata’s solid business development and investor relations expertise will provide Amida with a dedicated focus in its continued effort to raise investor awareness. We are building out and strategically strengthening our marketing efforts. As Amida’s CMO, Renata will help us execute marketing and client service strategies focusing on institutional and consultant relationships, as well as wealth management firms and private banks,” said David Rich.

Ms. Cirne brings with her over thirteen years of financial markets business development and investor relations expertise. She was most recently marketing consultant to Kylin Capital Management, a $1.6bn long/short equity hedge fund. Prior to that, Ms. Cirne spent nine years at Tremont Capital Management, a $10bn fund-of-funds, where she managed the firm’s strategic relationships with institutional clients, consultants and high net-worth investors. Prior to Tremont, Renata worked at Westchester Capital Management, a $2bn event driven hedge fund.

Ms. Cirne graduated with a B.S. (cum laude) in Business Management from Iona College. She also received certificates in Financial Management from Cornell University and in Wealth Management from the New York Institute of Finance.

Amida Capital Management II, LLC, was founded in January 2007, and is a New York based investment advisor to two master funds. Amida Partners Master Fund, Ltd., a relative value fund, focuses on multi-strategies and invests globally across the entire capital structure, with an emphasis on absolute value, relative value, and event driven strategies. Amida Partners Special Opportunity Master Fund, Ltd., a convertible arbitrage fund, invests globally and utilizes convertibles combined with various hedges to capitalize on volatility, mispriced capital structures, and issuer corporate actions. The investment objective of each fund is to generate attractive, absolute, non-correlated market returns with an emphasis on capital preservation.

For questions concerning this press release or information regarding Amida please contact Renata Cirne at 646-381-3938 or renata.cirne@amidapartners.com.

(press release)

kb

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. Opalesque Exclusive: U.S. legal receivables fund launched in August[more]

    Benedicte Gravrand, Opalesque Geneva for New Managers: Investing in asset-backed receivables is a strategy that has been an integral part of the alternative investment space within the overall fixed income asset c

  5. Comment - High fees and low performance hit hedge funds[more]

    From FT.com: Disenchantment over high fees and lackluster performance may finally be turning the tide against hedge funds, fresh data suggest. Despite generally weak returns since the global financial crisis, hedge funds have enjoyed positive net inflows every year since 2010. This helped assets und